Technical Analysis for TRIL - Trillium Therapeutics Inc.

Grade Last Price % Change Price Change
grade F 0.286 2.36% 0.01
TRIL closed up 2.36 percent on Monday, August 19, 2019, on 43 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Down
See historical TRIL trend table...

Date Alert Name Type % Chg
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.00%
NR7 Range Contraction 0.00%
NR7-2 Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Up 3 Days in a Row Strength 0.00%
Oversold Stochastic Weakness 0.00%
Stochastic Buy Signal Bullish 2.36%
NR7 Range Contraction 2.36%
Lower Bollinger Band Walk Weakness 2.36%
Wide Bands Range Expansion 2.36%

Older signals for TRIL ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Trillium Therapeutics Inc. is an immuno-oncology company developing innovative therapies for the treatment of cancer. The Company has two premier preclinical programs, SIRPaFc and a CD200 monoclonal antibody (mAb), which target two key immunoregulatory pathways that tumor cells exploit to evade the host immune system. SIRPaFc is an antibody-like fusion protein that blocks the activity of CD47, a molecule that is upregulated on tumor cells in acute myeloid leukemia (AML) and numerous other malignancies. The CD200 mAb is a fully human monoclonal antibody that blocks the activity of CD200, an immunosuppressive molecule that is overexpressed by many hematopoietic and solid tumors. For more information visit: www.trilliumtherapeutics.com
Medicine Cancer Medical Specialties Immunology Treatment Of Cancer Immune System Cancer Immunotherapy Tumor Acute Myeloid Leukemia Monoclonal Antibody Antibody Drug Conjugates Cancer Research CD47
Is TRIL a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 6.75
52 Week Low 0.24
Average Volume 263,845
200-Day Moving Average 1.1028
50-Day Moving Average 0.3403
20-Day Moving Average 0.3201
10-Day Moving Average 0.2961
Average True Range 0.0306
ADX 22.07
+DI 12.0552
-DI 24.1339
Chandelier Exit (Long, 3 ATRs ) 0.2882
Chandelier Exit (Short, 3 ATRs ) 0.3318
Upper Bollinger Band 0.3849
Lower Bollinger Band 0.2553
Percent B (%b) 0.24
BandWidth 40.487348
MACD Line -0.0222
MACD Signal Line -0.0177
MACD Histogram -0.0045
Fundamentals Value
Market Cap 3.09 Million
Num Shares 10.8 Million
EPS -4.08
Price-to-Earnings (P/E) Ratio -0.07
Price-to-Sales 0.00
Price-to-Book 4.22
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.32
Resistance 3 (R3) 0.32 0.31 0.32
Resistance 2 (R2) 0.31 0.30 0.31 0.31
Resistance 1 (R1) 0.30 0.30 0.29 0.30 0.31
Pivot Point 0.29 0.29 0.28 0.29 0.29
Support 1 (S1) 0.27 0.28 0.27 0.27 0.26
Support 2 (S2) 0.26 0.27 0.26 0.26
Support 3 (S3) 0.25 0.26 0.26
Support 4 (S4) 0.25